Healthy Skepticism Library

Items published during the years 1990 to 1999

There are 2362 items in the Healthy Skepticism Library that were published during the years 1990 to 1999.

Page 17 of 24 pages ‹ First  < 15 16 17 18 19 >  Last ›

HSL5255
Sheldeon TA, Smith GD.
Consensus conferences as drug promotion
Lancet 1993; 341:499

HSL5256
Sommers E.
Drug advertising
Canadian Medical Association Journal 1993; 146:1230

HSL5513
Squires BP.
Truth in advertising
Canadian Medical Association Journal 1993; 148:1663

HSL5519
Harrison V
An overview of current guidelines for commercial support of continuing medical education
Journal of Continuing Education in the Health Professions 1993; 13:68-76

HSL5520
Van HARRISON, Stross JK.
Requirements for speakers at “promotional” educational activities versus independent CME activities
Academic Medicine 1993; 83:841-842

HSL5522
Wakefield IR.
Pharmaceutical company sponsorship
New Zealand Medical Journal 1993; 106:232

HSL5524
Weintraub M.
Changing over-the-counter drugs while retaining the brand name
Annals of Internal Medicine 1993; 118:988

HSL5544
Ragg M.
The drug pushers
The Bulletin 1993

HSL5547
Keen PJ.
Pharmaceutical advertising controls - the future
Journal of the Royal Society of Medicine 1993; 86:237-239

HSL9295
Novitch M.
Implications of global drug development for health care and patients
Drug Inf J 1993; 27:(4):1083-1087

HSL9316
Starr C.
Which drugs are going off patent or losing exclusivity?
Drug Top 1993; 37:14S-15S

HSL9322
Young AL, Rave NL.
Product liability considerations in prescription drug labeling
Drug Inf J 1993; 27:(3):915-920

HSL9323
Butler T.
Hospital pharmacy-the pharmaceutical industry perspective
Pharm Manage England 1993; 8:

HSL9372
Basara LR.
Direct to consumer advertising: another perspective
Pharmacy Business 1993; 4:(1):15-18

HSL9373
Madhavan S.
Are we ready for direct to consumer advertising of prescription drugs?
Pharmacy Business 1993; 4:(1):14, 18-20, 28

HSL9376
Alsobrook HB.
Training and monitoring the pharmaceutical sales force
Drug Information Journal 1993; 27:(1):217-225

HSL11546
Miller D, Williams K.
Negotiating HIV/AIDS Information: Agendas, Media Strategies and the News
Eldridge J. Getting the Message: News, Truth and Power London: Routledge 1993
http://www.amazon.com/Getting-Message-Truth-Communication-Society/dp/0415079845/ref=sr_1_5/102-5869202-0212934?ie=UTF8&s=books&qid=1190533404&sr=1-5

HSL13273
Freeman JK, Barnes JH, Summers KH, Szeinbach SL
Modeling Physicians' Prescribing Decisions for Patients With Panic Disorder
Journal of Health Care Marketing 1993 Winter; 13:(1):34-39

HSL16724
Wolfe SM.
A Public Citizen Health Research Group perspective on federal triplicate prescription requirements for controlled substance prescription drugs.
NIDA Res Monogr 1993; 131:270-8:
http://www.ncbi.nlm.nih.gov/pubmed/8413540

HSL16725
Himmelstein D, Wolfe S, Woolhandler S
Mangled Competition
American Prospect 1993

HSL4320
Brodsky JF.
Pharmaceutical promotions.
N Engl J Med 1992 Dec 3; 327:(23):1687

HSL4323
Cassel CK.
Pharmaceutical promotions.
N Engl J Med 1992 Dec 3; 327:(23):1687-8

HSL4343
Frumin M, Komaromy M, O'Shea JD.
Pharmaceutical promotions.
N Engl J Med 1992 Dec 3; 327:(23):1687

HSL4347
Glass AR.
Pharmaceutical advertising in the Journal.
N Engl J Med 1992 Dec 3; 327:(23):1688

HSL4358
Kallir J.
Pharmaceutical promotions.
N Engl J Med 1992 Dec 3; 327:(23):1686-7

HSL4360
Katz AM.
Pharmaceutical promotions.
N Engl J Med 1992 Dec 3; 327:(23):1687

HSL4410
Pierach CA.
Pharmaceutical advertising in the Journal.
N Engl J Med 1992 Dec 3; 327:(23):1688-9

HSL4426
Sobel BJ.
Pharmaceutical promotions.
N Engl J Med 1992 Dec 3; 327:(23):1686

HSL19746
Sobel BJ, Tarshis GA, Rosenberg SJ, Anacker A, Kallir J, Katz AM, Woolley RJ, Ende M, Frumin M, Komaromy M, O'Shea JD, Forrest JV, Brodsky JF, Cassel CK, Waud DR
Pharmaceutical Promotions
NEJM 1992 Dec 3; 327:1686-1688
http://www.nejm.org/doi/full/10.1056/NEJM199212033272313

HSL4450
Wieringa NF, de Meijer AH, Schutjens MD, Vos R.
The gap between legal rules and practice in advertising non-registered pharmaceutical products. A new method of analysis
Soc Sci Med. 1992 Dec 01; 35:(12):1497-504

HSL4646
Shapiro MF.
Critics dissect, authors defend Wilkes paper on advertising [author's response]
Medical Marketing & Media 1992 Dec 1; 27:(12):18-19

HSL2145
Cormack MA, Howells E.
Factors linked to the prescribing of benzodiazepines by general practice principals and trainees.
Fam Pract 1992 Dec; 9:(4):466-71

HSL4652
Organon, the IFPMA Code and the WHO Ethical Criteria
MaLAM International Newsletter 1992 Dec; 1-2

HSL4653
Dower , Moira .
DTC ads for Europe?
Scrip Mag 1992-1993 Dec-Jan; (10):10

HSL9386
Hopefl AW.
Costs of pharmaceutical care: can the profession do anything?
Ann Pharmacother 1992 Dec; 26:(12):1585-8

HSL9392
Chi J.
FDA tries again for improved pediatric labels: will it work?
Drug Topics 1992 Dec; 136:9

HSL9404
Penick TM, Smith MC.
Content analysis of appeals used in advertising in the American Journal of Hospital Pharmacy in 1960, 1970, 1980, and 1990
ASHP Midyear Clinical Meeting 1992 Dec; 27:

HSL4651
New code workshop
PMAC Bulletin 1992 Nov 30; 15:(92):6-9

HSL4650
U.S. Food and Drug Administration
Draft policy statement on industry-supported scientific and educational activities
Fed Regist. 1992 Nov 29; 57:(229):56412-56414.

HSL20241
Chetley A
Bangladesh: Changes to drug policy
The Lancet 1992 Nov 21; 340:(8830):1280 - 1281
http://www.lancet.com/journals/lancet/article/PII0140-6736%2892%2992969-M/fulltext

HSL4357
Jablonsky G.
Physicians and the pharmaceutical industry.
CMAJ 1992 Nov 15; 147:(10):1415

HSL4456
Wortis J, Stone A.
The addiction of drug companies.
Biol Psychiatry 1992 Nov 15; 32:(10):847-9

HSL4649
Ukens C.
Consumer advertising found to pack prescribing punch
Drug Topics 1992 Nov 9; 136:(21):24, 26

HSL9382
Conlan MF.
Congress leaves mixed record, with much to revisit in "93
Drug Topics 1992 Nov 9; 136:82, 84, 88

HSL4643
Jacoby , J .
Critics dissect, authors defend Wilkes paper on advertising [1st of 4 critiques]
Medical Marketing & Media 1992 Nov 5; 27:(12):16-17

HSL4641
Re: the promotion of aspirin
1992 Nov 1;

HSL4642
Castagnoli , William G.
Critics dissect, authors defend Wilkes paper on advertising
Medical Marketing & Media 1992 Nov 1; 27:(12):14-20, 22

HSL4644
Rubin , Paul H.
Critics dissect, authors defend Wilkes paper on advertising [3rd of 4 critiques]
Medical Marketing & Media 1992 Nov 1; 27:(12):17-18

HSL4645
Schmittlein , David .
Critics dissect, authors defend Wilkes paper on advertising [2nd of 4 critiques]
Medical Marketing & Media 1992 Nov 1; 27:(12):17

HSL4647
Spiro HM.
Speaking out: A physician looks at direct-to-consumer advertising
Medical Marketing & Media 1992 Nov 1; 27:(11):24, 26, 28

HSL4648
Wilkes MS.
Critics dissect, authors defend Wilkes paper on advertising [summary of the research]
Medical Marketing & Media 1992 Nov 1; 27:(12):15-16

HSL4327
Chren MM.
Industry-funded dermatologic research within academia in the United States: fiscal and ethical considerations.
J Invest Dermatol 1992 Nov; 99:(5):664-5

HSL9319
Bentkover JD, Baker AM.
Prosperous changes: new pricing plans spell success
Pharm Exec 1992 Nov; 12:76, 78, 80, 82, 84

HSL9320
Schwartz H.
Demeaning industry-inside and out
Pharm Exec 1992 Nov; 12:19-20, 22

HSL9371
New directions in pharmaceutical industry
Pharma Times 1992 Nov; 24:7

HSL9381
Zoo full of unicorns
National Association of Retail Druggists Journal 1992 Nov; 113:28-31

HSL9401
More awareness of free drug programs for indigent patients is needed, says Senate committee on aging
American Journal of Hospital Pharmacy 1992 Nov; 49:2646

HSL20370
Bradley CP
Factors which influence the decision whether or not to prescribe: the dilemma facing general practitioners
BMJ 1992 Nov; 42:454-458
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1372266/

HSL4303
Agzarian AY.
Pharmaceutical ads in journals.
Ann Intern Med 1992 Oct 1; 117:(7):618

HSL4306
Angel JF.
Pharmaceutical ads in journals.
Ann Intern Med 1992 Oct 1; 117:(7):616-7

HSL4312
Beary JF 3rd.
Pharmaceutical ads in journals.
Ann Intern Med 1992 Oct 1; 117:(7):616

HSL4369
Lexchin J.
Pharmaceutical ads in journals.
Ann Intern Med 1992 Oct 1; 117:(7):617

HSL4371
Liebman M.
Pharmaceutical ads in journals.
Ann Intern Med 1992 Oct 1; 117:(7):617

HSL4401
Noble RC.
Pharmaceutical ads in journals.
Ann Intern Med 1992 Oct 1; 117:(7):617-8

HSL4640
Scanlan C .
Unsafe drugs find buyers abroad
MaLAM International Newsletter 1992 Oct 1; 3-6

HSL4502
Africa survey shows pharma information valued
Health Horizons 1992 Oct; (17):12-13

HSL4503
Way to irrational medical practice
HAI News 1992 Oct; (67):12

HSL4504
Whither WHO’s ethical criteria?
Health Horizons 1992 Oct; (17):26

HSL4505
Chetley A.
Promoting health or pushing drugs?
HAI News 1992 Oct; (67):1-2, 10-12

HSL4506
Preuss K.
New approaches to promotion in the EC
Scrip Magazine 1992 Oct; (8):23-26

HSL9400
Lesar TS.
Common prescribing errors.
Ann Intern Med 1992 Sep 15; 117:(6):537-8

HSL4377
McMahon R.
Beware of offers of indemnity.
N Engl J Med 1992 Sep 10; 327:(11):819-20

HSL4374
Martin WR.
Drug information discrepancy.
CMAJ 1992 Sep 1; 147:(5):584,

HSL4501
Guidelines for faculty involvement in commercially supported continuing medical education.
Academic Medicine 1992 Sep 01; 67:(9):616-621

HSL1861
Banks JW 3rd, Mainous AG 3rd.
Attitudes of medical school faculty toward gifts from the pharmaceutical industry.
Acad Med 1992 Sep; 67:(9):610-2

HSL4500
Re: the promotion of nimodipine
1992 Sep

HSL9397
Blauvelt BM.
Challenges of OTC marketing in South Korea
Pharmaceutical Executive 1992 Sep; 12:70, 72, 74-75, 77-78, 80

HSL4499
Cotts C.
The pushers in the suites
The Nation 1992 Aug-Sep 31-7208, 210-211

HSL1870
Brotzman GL, Mark DH.
Policy recommendations for pharmaceutical representative-resident interactions.
Fam Med 1992 Aug; 24:(6):431-2

HSL4349
Goldsmith R.
Baby's first spring water.
Pediatrics 1992 Aug; 90:(2):

HSL4368
Levy G.
Publication bias: its implications for clinical pharmacology.
Clin Pharmacol Ther 1992 Aug; 52:(2):115-9

HSL4412
Procopio L.
Physicians' interactions with pharmaceutical companies.
Pediatrics 1992 Aug; 90:(2):

HSL4498
New policy: physicians and the pharmaceutical industry
1992 Aug

HSL9391
Discola J.
Microcomputer applications in health care delivery: focus on cost containment aspects.
AAPPO J 1992 Aug-Sep; 2:(4):11-6

HSL9395
Naccarelli GV, Dougherty AH, Jalal S, Shih HT, Gilman J.
Cardiac Arrhythmia Suppression Trial (CAST): interpretation of the findings and effect on drug development and prescribing practices
Hospital Formulary 1992 Aug; 27:792-793, 797-798, 801-802, 805

HSL9403
Wechsler J.
Regulating drug promotion: more harm than good?
Pharmaceutical Technology 1992 Aug; 16:18, 20, 22, 24

HSL19963
Emmett M
Pills, pedlars, profits and power
Media Information Australia 1992 Aug; (65):36-42
http://search.informit.com.au/documentSummary;dn=136865841695634;res=IELLCC

HSL4400
Noble RC.
Education or promotion?
N Engl J Med 1992 Jul 30; 327:(5):363-4

HSL4448
Waud DR.
Pharmaceutical promotions--a free lunch?
N Engl J Med 1992 Jul 30; 327:(5):351-3

HSL16722
Wolfe SM, Lurie P.
Regulation of benzodiazepine prescription.
JAMA 1992 Jul 22-29; 268:(4):472
http://www.ncbi.nlm.nih.gov/pubmed/1352360

HSL16723
Lurie P, Kahn JG, Wolfe SM.
Regulation of benzodiazepine prescription.
JAMA 1992 Jul 22-29; 268:(4):472-3
http://www.ncbi.nlm.nih.gov/pubmed/1352361

HSL1844
Bucci KK, Frey KA.
A description of a pharmacotherapy curriculum in a university-based family medicine program.
Ann Pharmacother 1992 Jul-Aug; 26:(7-8):991-4

HSL2139
Orlowski JP, Wateska L.
The effects of pharmaceutical firm enticements on physician prescribing patterns. There's no such thing as a free lunch.
Chest 1992 Jul; 102:(1):270-3
http://www.chestjournal.org/cgi/search?pubdate_year=1992&volume=&firstpage=&author1=Orlowski+JP++&author2=Wateska+L&title=&andorexacttitle=and&titleabstract=&andorexacttitleabs=and&fulltext=&andorexactfulltext=and&journalcode=chest&fmonth=Apr&fyear=1965&tmonth=Aug&tyear=2005&fdatedef=1+April+1965&tdatedef=1+August+2005&flag=&RESULTFORMAT=1&hits=10&hitsbrief=25&sortspec=relevance&sortspecbrief=relevance&sendit=Search

HSL4417
Rosner F.
Ethical relationships between drug companies and the medical profession.
Chest 1992 Jul; 102:(1):266-9

HSL4493
Summary of correspondence outcomes for topics commenced June ’90—March ’91
MaLAM Newsletter 1992 Jul

HSL4494
Cowhig J.
Medical publishing
1992 Jul

HSL4495
Promotion and advertising of therapeutic goods: final report
1992 Jul

HSL4496
Darbourne A.
Pharmaceuticals in the Third World—progress or crisis?
Scrip Magazine 1992 Jul-Aug; (6):6-8

HSL4497
Schwartz H.
The medical journals and drug advertising—the Schwartz view
Scrip Magazine 1992 Jul-Aug; (6):15-16

HSL9390
Brenner L.
Where muscle pricing counts
American Druggist 1992 Jul; 206:58-59, 63

Page 17 of 24 pages ‹ First  < 15 16 17 18 19 >  Last ›